AzTrials
AzTrials

Urinary Tract InfectionNCT03577769

Nosocomial Bacteriuria in Geriatric Internal Medicine Services and Follow-up Care and Geriatric Rehabilitation of the Strasbourg University Hospitals

An observational study of Urinary Tract Infection, run by University Hospital, Strasbourg, France at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This thesis is a comparative study of the epidemiological characteristics of health-care associated bacteriuria in short and medium term of geriatrics wards in Strasbourg's University Hospital, between 2003 and 2017, in the follow-up of Eric de Pasquale's thesis in 2010. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Urinary Tract Infection
How many people
200 participants
Where
1 siteFrance
Study dates
1 Jun 2018to Jun 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: * patient of age who has been hospitalized in geriatric wards (rehabilitation car service and internal medicine) of Strasbourg's University hospital * date of hospital leaving after 1/1/17 and before 1/1/18 * patient who has a health-care urinary tract infection (occurred more than 48h after admission)

Who may be able to join

  • patient of age who has been hospitalized in geriatric wards (rehabilitation car service and internal medicine) of Strasbourg's University hospital
  • date of hospital leaving after 1/1/17 and before 1/1/18
  • patient who has a health-care urinary tract infection (occurred more than 48h after admission)
  • single bacteria in the CBEU
  • bacteriuria > 105 cfu/mL regardless which clinical context or bacteria
  • if a patient has several bacteriuria, they can be included if they appear after a precedent episode well treated or if the bacteria is different from the precedent

Who cannot join

  • participation refusal
  • Leaving of hospital out of the inclusion period
  • Urinary tract infection which occurred less than 48h after admission (communitarian infection)
  • bacteriuria < 105 cfu/mL
  • multiple bacteria in the CBEU

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Service Geriatrie - Soins de Suite Et Readaptation

    Strasbourg, 67091

    Catherine JEHL, MD, 33 3 88 11 55 11, catherine.jehl@chru-strasbourg.fr

    MARIE ROUSSEL, MD, 33 3 88 11 55 11, marie.nouet@gmail.commarie.roussel@chru-strasbourg.fr

    Recruiting

Other trials in France

About this study

Official title: Health Care-associated Bacteriuria in Geriatric Wards in Strasbourg's University Hospital : a Comparative Study of Bacterial Ecology Between 2003, 2007 and 2017

This thesis is a comparative study of the epidemiological characteristics of health-care associated bacteriuria in short and medium term of geriatrics wards in Strasbourg's University Hospital, between 2003 and 2017, in the follow-up of Eric de Pasquale's thesis in 2010.

This comparative study will allow to see the evolution of urinary bacterial ecology, bacterial sensitivity to antibiotics, and the part of multi-resistant bacteria, during these 14 years in geriatric services in Strasbourg.

Keywords
Health care associated urinary tract infection, Bacteriuria, Elderly, Geriatrics, Antimicrobial resistance, Multi-resistant bacteria
Medical subject headings
Urinary Tract Infections, Bacteriuria

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bacterial sensitivity (antibiotic resistance testing)

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2018
  2. Study start1 Jun 2018
  3. Primary completionJun 2019 (estimated)
  4. Study completionJun 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03577769
Sponsor's protocol ID
7024
Status last verified
Jun 2018
First submitted
21 Jun 2018
Last updated
5 Jul 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Urinary Tract Infection, run by University Hospital, Strasbourg, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Catherine JEHL, MD (33 3 88 11 55 11, catherine.jehl@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bacterial sensitivity (antibiotic resistance testing) (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in